Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD to...

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming educational session highlighting the role of radiopharmaceuticals, including ... (more)

http://ift.tt/1jlQxxF